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The molecular mechanisms governing severe acute respiratory syndrome coronavirus-induced
pathology are not fully understood. Virus infection and some individual viral proteins, including the
3a protein, induce apoptosis. However, the cellular targets leading to 3a protein-mediated
apoptosis have not been fully characterized. This study showed that the 3a protein modulates the
mitochondrial death pathway in two possible ways. Activation of caspase-8 through extrinsic
signal(s) caused Bid activation. In the intrinsic pathway, there was activation of caspase-9 and
cytochrome c release from the mitochondria. This was the result of increased Bax oligomerization
and higher levels of p53 in 3a protein-expressing cells, which depended on the activation of
p38 MAP kinase (MAPK) in these cells. For p38 activation and apoptosis induction, the 3a
cytoplasmic domain was sufficient. In direct Annexin V staining assays, the 3a protein-expressing
cells showed increased apoptosis that was attenuated with the p38 MAPK inhibitor SB203580.
A block in nuclear translocation of the STAT3 transcription factor in cells expressing the 3a
protein was also observed. These results have been used to present a model of 3a-mediated
apoptosis.
INTRODUCTION
The aetiological agent for severe acute respiratory syn-
drome (SARS) was identified as a novel coronavirus
(SARS-CoV) (Peiris et al., 2003). SARS-CoV has a
polyadenylated, positive-sense RNA genome of approxi-
mately 30 kb (Marra et al., 2003). In addition to the
prototypic coronavirus genes, the SARS-CoV genome also
contains nine unique open reading frames (ORFs) (Marra
et al., 2003). Of these, orf3a is the largest and encodes a
protein of 274 aa, variously called ORF3A (Ito et al., 2005),
X1 (Rota et al., 2003) or U274 (Tan et al., 2004b). The 3a
protein has been predicted to contain an N-terminal signal
peptide followed by three transmembrane domains and a
C-terminal cytoplasmic domain of approximately 150 aa
(Zeng et al., 2004).
The 3a protein is associated with virus particles produced
following infection of Vero E6 or Caco-2 cells (Ito et al.,
2005; Shen et al., 2005) and can assemble into virus-like
particles when co-expressed with the membrane and
envelope proteins in insect cells (Shen et al., 2005). In
vitro studies have also shown the 3a protein to interact with
the viral envelope, membrane and spike proteins (Tan et al.,
2004b; Tan, 2005) and the cellular protein caveolin-1
(Padhan et al., 2007). A deletion of orf3a was shown to
reduce virus titres, but not to eliminate virus replication
(Yount et al., 2005), and convalescent sera from SARS
patients have antibodies to the 3a protein (Tan et al.,
2004a), suggesting that it is expressed during virus
infection of the host. The 3a protein was shown to
upregulate the expression of fibrinogen in A549 lung
epithelial cells (Tan et al., 2005) and to possess an ion-
channel activity selective for monovalent cations (Lu et al.,
2006).
Ectopic expression of the 3a protein has been shown to
induce apoptosis in Vero E6 cells through activation of
caspase-8, chromatin condensation and DNA fragmenta-
tion (Law et al., 2005). In a Drosophila melanogaster
expression system, it was also found to modulate cellular
cytochrome c levels and caspase activity (Wong et al.,
2005). It has recently been shown to induce G1-phase cell
cycle arrest via the cyclin D3/pRb pathway in HEK293,
COS-7 and Vero cells (Yuan et al., 2007).
Apoptosis is a cell-death programme that is initiated in
response to various extrinsic and intrinsic signals such as
cellular stress, including virus infection, and plays an
important role in the pathogenesis of many viruses (Wang
et al., 2007). The extrinsic pathway initiates at the cell
surface following occupation of death receptors by their
cognate ligands; the best examples of this are the Fas/Fas
ligand and tumour necrosis factor receptor (TNFR)/TNF
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pathways (Tartaglia et al., 1993). The intrinsic pathway is
controlled by multiple sensor proteins, such as those of the
Bcl-2 family, and initiates at the mitochondria, leading to
their depolarization and leakage of molecules such as
cytochrome c (Green & Kroemer, 2004). Following the
initial signal and its transduction, the effector caspases are
activated, causing the activation of endonucleases and
degradation of cellular proteins (Zou et al., 1999). Whilst
different caspases are activated downstream of the extrinsic
and intrinsic pathways – caspase-8 for the former and
caspase-9 for the latter – the signal is eventually integrated
through the activation of caspase-3, the central effector for
both pathways (Mayer & Oberbauer, 2003).
The Bcl-2 family includes both pro-apoptotic (Bad, Bak
and Bax) and anti-apoptotic (Bcl-2 and Bcl-XL) proteins
that are critical modulators of the intrinsic death pathway
(Adams & Cory, 1998). The multi-domain Bax protein
exists as a monomer in the cytoplasm of viable cells, but
upon stimulation by various death insults it undergoes
conformational changes, dimerizes and translocates to the
mitochondria, where it inserts into the outer membrane,
causing the release of cytochrome c (Wolter et al., 1997).
The BH3-only pro-apoptotic proteins Bid, Bim, Noxa,
Puma and as-yet-unidentified proteins or lipids mediate
induction of the active conformation of Bax by death
stimuli (Kuwana et al., 2002; Oda et al., 2000). This is
either through association with anti-apoptotic Bcl-2 family
members or by stimulating other apoptosis-promoting
factors (Chen et al., 2005). Many apoptotic stimuli utilize
Bax to kill cells (Zhang et al., 2000). Its overexpression
alone is also sufficient to induce apoptosis in many cell
types (Xiang et al., 2000). The tumour suppressor and
transcription factor p53 can also enhance the pro-
apoptotic activity of Bax, either by inducing its expression
or by sequestrating Bcl-2 or Bcl-XL in the cytoplasm
(Miyashita & Reed, 1995).
We show here that, in addition to caspase-8 activation
(Law et al., 2005), the SARS-CoV 3a protein also activates
caspase-9 and other elements of the intrinsic pathway,
including cytochrome c release, Bax oligomerization, p53
upregulation and p38 MAP kinase (MAPK) activation. We
also show p38 MAPK activation to be important for the
pro-apoptotic effects of the 3a protein.
METHODS
Materials and plasmids. All common reagents were from Sigma
Chemical Co. unless otherwise stated. Huh7 cells were cultured at
37 uC in 10% CO2 in complete Dulbecco’s modified Eagle medium
and 10% fetal bovine serum. Antibodies generated against a
recombinant 3a protein have been described previously (Padhan et
al., 2007). Antibodies to caspase-3, cleaved caspase-3, caspase-9,
cleaved caspase-9 and cleaved PARP were part of the Apoptosis
Sampler kit (Cell Signaling Technology). All other antibodies were
obtained from either Santa Cruz Biotechnology or Cell Signaling
Technology. The phospho-specific antibodies included: pErk (T202/
Y204), pJNK (T183/Y185), pp38 (T180/Y182), pMKK3/6 (S189/207)
and pStat3 (Y705) (Cell Signaling Technology). The cloning of orf3a
and construction of the pSGI-3a-HA, pSG-3a-cyto, 3a-ECFP and 3a-
DsRed expression vectors has been described previously (Padhan et
al., 2007). The pEGFP-cytC plasmid was a gift from Dr Israrul Haq
Ansari (University of Nebraska, Lincoln, USA). The STAT3 reporter
pLucTKS3 and the control pLucTK plasmids were obtained from Dr
Gulam Waris (University of Colorado Medical School, USA). The
STAT3-EGFP plasmid was a kind gift of the Darnell laboratory
(Rockefeller University, NY, USA).
Transfection and Western blotting. Typically, 5 mg plasmid DNA
was used for each 60 mm dish of Huh7 cells. Transfections were
carried out using Lipofectin reagent (Invitrogen) according to the
manufacturer’s instructions. At the indicated times post-transfection
(p.t.), cells were scraped, lysed in 16 cell lysis buffer [20 mM Tris/
HCl (pH 8), 150 mM NaCl, 1% Triton X-100, 1 mM EDTA, 1 mM
EGTA, 1 mM NaF, 1 mM sodium orthovanadate and protease
inhibitor cocktail (Roche)] and clarified by centrifugation at 16 000 g
for 20 min at 4 uC. The protein concentration of the lysate was
estimated using Bradford reagent (Bio-Rad). Western blotting was
carried out as described elsewhere (Padhan et al., 2007).
Cross-linking experiments. Transfected Huh7 cells were washed
and harvested in PBS at 48 h p.t. The p38 inhibitor SB203580 (Sigma)
was added 12 h before harvest at a concentration of 20 mM in fresh
complete medium. Washed cells were resuspended in PBS containing
protease inhibitor cocktail (Roche) and lysed by repeated freeze–thaw
cycles in liquid N2 and 37 uC. The unclarified lysate was then cross-
linked with 10 mM disuccinimidyl suberate (DSS; Sigma) at 30 uC for
30 min and the reaction stopped with 50 mM Tris/HCl (pH 8.0). The
lysate was then prepared in 26 in SDS loading buffer, boiled and
separated by 10% SDS-PAGE.
Immunofluorescence and subcellular localization. Cells grown
on coverslips to 40–50% confluence were transfected and then
imaged as described previously (Padhan et al., 2007). For subcellular
localization of cytochrome c, Huh7 cells were co-transfected with
pEGFP-cytC and pDsRed-mito (Clontech) either with or without
plasmid 3a-ECFP. The percentage co-localization was calculated using
LaserPix software (Bio-Rad). For STAT3 imaging, Huh7 cells were co-
transfected with the STAT3-EGFP vector together with either the 3a-
DsRed or the pDsRed-N1 plasmid. After 36 h, cells were serum-
starved overnight and then treated with 100 ng epidermal growth
factor (EGF) ml21 for 3 h, washed with PBS and imaged.
Flow cytometry. Huh7 cells were transfected as above and, 36 h
later, the cells were switched to fresh medium containing 20 mM
SB203580 for 12 h. Subsequently, 1.56106–1.86106 cells were
harvested in 0.02% EDTA, washed twice with PBS and stained with
3 ml phycoerythrin (PE)-conjugated Annexin V (BD Pharmingen) in
40 ml binding buffer [10 mM HEPES (pH 7.4), 140 mM NaCl,
2.5 mM CaCl2]. The cells were then fixed with 100 ml fixative
(Intrastain kit; Dako) for 15 min at room temperature and washed
with PBS. The pellet was resuspended in 100 ml permeabilization
buffer (Intrastain kit; Dako) at room temperature for 15 min. After
washing with PBS, the cells were resuspended in 1 : 100-diluted rabbit
anti-3a and incubated for 30 min at room temperature, followed by
two washes in PBS. The cells were then counterstained with 1 : 500-
diluted Alexa 488-conjugated anti-rabbit antibody (Molecular
Probes) at room temperature for 45 min. After two washes in PBS
containing 1% BSA, the cells were resuspended in 400 ml of the same
buffer for acquisition. For each sample, 30 000 events were acquired
using a CyAn-ADP flow cytometer (Dako) and the data analysed
using Summit software (version 4.3). The cells were gated for 3a
expression, and Annexin V staining was determined in 3a-positive
and -negative cells, the latter being treated as controls. Apoptosis
(±SD) was calculated over four different experiments and the results
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were calculated as percentage values. P values were calculated using
Student’s t-test with 95% confidence intervals.
Luciferase assay. Transfected cells were collected at 36 h p.t.,
serum-starved overnight and then treated with 100 ng EGF ml21 for
3 h, washed with PBS and harvested. The preparation of cytosolic
extracts and luciferase assays were carried out using a Luciferase assay
kit (Promega) according to the supplier’s protocol and readings were
taken on a luminometer (Sirius).
RESULTS
SARS-CoV 3a protein activates the intrinsic
pathway of apoptosis
The 3a protein has been shown previously to induce
apoptosis in Vero E6 cells. In this system, there was
increased caspase-8 activation, but no change in Bad or
Bcl-2 levels, suggesting that the death-receptor (extrinsic)
apoptosis pathway was activated (Law et al., 2005). We
chose to study the apoptotic activity of the 3a protein in
the Huh7 human hepatocellular carcinoma cell line, as liver
cells have been shown to be permissive for SARS-CoV
infection and replication (Kaye, 2006). Furthermore, these
cells are negative for caveolin, unlike Vero or A549 cells
(Damm et al., 2005). We recently showed that the SARS-
CoV 3a protein interacts with caveolin (Padhan et al.,
2007), a cellular protein with multiple effects, including
effects on apoptosis (Timme et al., 2000). Huh7 cells
transfected with the pSGI-3a-HA or control plasmid were
harvested at different times and checked for various cell-
death markers by Western blotting. There was increased
activation (cleavage) of caspase-3, the central effector
caspase, and its downstream substrates caspase-7 and
PARP, in 3a protein-expressing cells (Fig. 1a). Caspase 3
can be activated by either caspase-8 from the extrinsic
pathway or caspase-9 from the intrinsic pathway. Higher
levels of cleaved caspase-9 were detected in 3a protein-
expressing cells, these effects being more prominent
following serum starvation (Fig. 1b). As the 3a protein
has been shown previously to activate caspase-8 (Law et al.,
2005), we also checked for cleavage of Bid. Truncated Bid
(tBid) has effects on the mitochondria and is important for
cross-talk between the extrinsic and intrinsic pathways
(Luo et al., 1998). Higher levels of tBid were observed in 3a
protein-expressing cells (Fig. 1c).
Another hallmark of the intrinsic pathway of apoptosis is
the release of cytochrome c from mitochondria. In Huh7
cells co-transfected with pEGFP-cytC and pDsRed-mito,
the cytochrome c signal was found quantitatively in the
mitochondria in the absence of 3a protein (Fig. 2, upper
panels). However, in cells that co-expressed 3a, cytochrome
c was found to be extra-mitochondrial (Fig. 2, middle
panels). The 3a protein itself did not localize to the
mitochondria (Fig. 2, lower panels) and was found
predominantly at the plasma membrane and in the Golgi
region, as shown previously (Padhan et al., 2007). On
image quantification across multiple cells that expressed
the 3a protein, only 7.1±4.0% of the cytochrome c signal
was found to co-localize with the mitochondrial marker.
Thus, caspase-9 activation and cytochrome c release in cells
expressing the 3a protein indicated that this viral protein
also activates the intrinsic pathway of apoptosis.
Bax oligomerization and p53 upregulation are
promoted by the 3a protein
Members of the Bcl-2 family of proteins play a major role
in regulating cytochrome c release from the mitochondria.
There were no significant differences in the levels of Bak,
Bcl-XL, Bcl-2 and Mcl-1, as well as the outer-mitochondrial
(a)
(b)
(c)
Fig. 1. Apoptosis markers in 3a protein-
expressing cells. (a) Huh7 cells were trans-
fected with pSG-3a or the control vector
pSGI. At various times, cell lysates were
analysed by Western blotting for the indicated
apoptosis marker proteins. (b) Transfected
Huh7 cells were either shifted to serum-free
medium at 36 h p.t. for 12 h or kept in serum-
containing medium. Cell lysates were analysed
by Western blotting. (c) Transfected Huh7
cells at 48 h p.t. were analysed by Western
blotting.
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membrane porin VDAC, in 3a protein-expressing versus
control cells (Fig. 3a). However, cells expressing the 3a
protein showed increased levels of oligomeric Bax (Fig. 3b).
These levels also varied with time, peaking at 48 h
following pSGI-3a-HA transfection of Huh7 cells.
Oligomeric Bax forms a channel in the outer-mitochon-
drial membrane through which cytochrome c and other
apoptogenic factors move into the cytosol.
The tumour suppressor protein p53 is pro-apoptotic and
works through diverse mechanisms. One of these is based
on the activation of bax transcription, as the p53-mediated
activation of Bax at cytoplasmic sites (Baptiste & Prives,
2004). We found an approximately twofold increase in the
levels of p53 in cells expressing the 3a protein at various
times p.t. (Fig. 3c). This is likely to be an underestimation,
as not all of the transiently transfected cells expressed the
3a protein. In multiple experiments, the transfection
efficiency was in the range of 40–50% of Huh7 cells.
The 3a protein causes p38-mediated upregulation
of p53
Many viral proteins regulate cell survival or death by
modulating the activity of the MAP kinase family of
proteins. In cells expressing the 3a protein, we found no
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Fig. 2. Cytochrome c is released from mito-
chondria in 3a protein-expressing cells. Huh7
cells were co-transfected with plasmids
pEGFP-cytC, pDsRed-mito and either 3a-
ECFP or pECFP (vector control). After 48 h,
cells were fixed and analysed by confocal
microscopy for the distribution of DsRed-mito
(mitochondrial marker), cytochrome c and 3a
protein. Individual pseudocoloured and
merged images are shown. The graph on the
right shows the percentage co-localization of
the mitochondrial marker and cytochrome c in
cells lacking or expressing the 3a protein. The
quantification is based on 20 cells of each
kind.
(a)
(b)
(c)
Fig. 3. The 3a protein promotes Bax oligo-
merization and upregulates p53. (a) Huh7 cells
at 48 h p.t. were analysed by Western blotting
for the indicated proteins. (b) Huh7 cells at
various times p.t. were analysed for Bax by
Western blotting. The 48 h sample was also
cross-linked with DSS, as described in
Methods, prior to SDS-PAGE and Western
blotting. (c) Huh7 cells at various times p.t.
were analysed for p53 levels by Western
blotting.
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change in pERK levels and only a small increase in pJNK
levels, but significant upregulation of p38 phosphorylation
(Fig. 4a). To confirm whether p38 mediated the 3a protein
effects, we employed SB203580, a specific inhibitor of p38
activity. As expected, SB203580 did not show any effect on
p38 phosphorylation. However, it abolished the increase in
p53 levels seen in 3a protein-expressing cells (Fig. 4b),
placing p53 downstream of p38. Treatment with SB203580
also reduced Bax oligomerization in cells expressing the 3a
protein (Fig. 4c). A small decrease in the levels of cleaved
PARP was also observed following SB203580 treatment
(Fig. 4b). Complete inhibition of PARP cleavage was not
expected, as the 3a protein can also induce apoptosis
through caspase-8; this would also contribute to PARP
cleavage, but would be insensitive to SB203580.
The activation of p38 is regulated by various stress signals
and is mediated by the upstream MAPK kinase isoforms 3
and 6 (MKK3/6). Increased levels of phosphorylated
(activated) MKK3/6 were also observed in 3a protein-
expressing cells (Fig. 4d). Taken together, these results
support a stress pathway-mediated p38 activation that is
directly responsible for p53 upregulation and Bax oligo-
merization in 3a protein-expressing cells.
The cytoplasmic domain of the 3a protein, but not
its caveolin-binding activity, is required for
apoptotic activity
The 3a protein of SARS-CoV is predicted to contain three
transmembrane regions (aa 34–56, 77–99 and 103–125)
and a C-terminal cytoplasmic domain of 149 aa.
Expression of the 3a cytoplasmic domain in Huh7 cells
led to increases in PARP cleavage and p38 phosphorylation
at levels similar to those observed with the full-length
protein (Fig. 5a). On densitometric quantification, cells
transfected with pSG-3a or pSG-3a-Cyto showed a mean
2.3- and 2.1-fold increase in cleaved PARP, respectively,
compared with vector-transfected cells. This indicated that
the 3a cytoplasmic domain was sufficient for its pro-
apoptotic effects.
We showed recently that the 3a protein interacts with
caveolin, a protein that regulates many cellular processes,
including apoptosis (Padhan et al., 2007). As the analysis
thus far was in caveolin-null Huh7 cells, we also tested the
pro-apoptotic effects of the 3a protein in caveolin-
expressing monkey kidney COS cells. Immunofluorescent
staining of caveolin and 3a protein was carried out in cells
transfected with pSG-3a. This confirmed that Huh7 cells
did not express caveolin whilst COS cells did, and that both
cells showed a similar intracellular distribution of ectopi-
cally expressed 3a protein (Fig. 5b). Western blotting of
COS cell lysates showed that, in this cellular background,
the 3a protein also induced PARP cleavage and p38 MAPK
activation (Fig. 5b). Other elements of the 3a protein-
mediated apoptotic pathway such as Bax oligomerization,
p53 upregulation and caspase-9 activation were also
observed in COS cells (Fig. 5c). These results suggested
that the pro-apoptotic nature of the 3a protein is not
influenced by its ability to bind caveolin.
Activation of p38 MAPK is important for 3a
protein-mediated apoptosis
The results reported thus far indirectly suggested a pro-
apoptotic role for the 3a protein. To demonstrate directly
an effect of the 3a protein on cell death, we measured the
ability of 3a protein-expressing and control cells to bind
Annexin V. An early event in apoptosis is the loss of
membrane phospholipid asymmetry, resulting in the
exposure of phosphatidylserine at the surface of the cell.
Annexin V binds with high affinity to phosphatidylserine
and this binding is used as a marker of apoptosis
(Koopman et al., 1994). Using flow cytometry, we
measured Annexin V binding to Huh7 cells that expressed
the 3a protein and compared this with control cells that did
not express the protein. There was a significant increase in
Annexin V binding to cells that expressed the 3a protein
(a) (b)
(c) (d)
Fig. 4. The 3a protein-mediated p53 upregulation and Bax
dimerization are p38-dependent. (a) Huh7 cells at 48 h p.t. were
analysed for various MAPKs by Western blotting. (b) Transfected
Huh7 cells at 36 h p.t. were shifted to fresh medium without
(mock) or with 20 mM SB203580. After 12 h, cell lysates were
prepared and analysed by Western blotting for the indicated
proteins. (c) Lysates prepared from transfected Huh7 cells either
treated with SB203580 or not were subjected to cross-linking
with DSS, as described in Methods. The lysates were then
Western blotted for Bax. (d) Lysates from Huh7 cells at 48 h p.t.
were analysed for pMKK3/6 by Western blotting.
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compared with control cells (Fig. 6a). However, treatment
of the 3a protein-expressing cells with the p38 MAPK
inhibitor SB203580 led to reduced Annexin V binding
(Fig. 6a). In four separate experiments, we observed a mean
of approximately 40% of cells expressing the 3a protein
undergoing apoptosis, compared with ,0.5% of control
cells. Treatment with SB203580 reduced this to about half,
with a mean of 19% of 3a-expressing cells demonstrating
apoptosis (Fig. 6b). This indicated that p38 MAPK
activation is important for the apoptosis of 3a protein-
expressing cells.
The 3a protein inhibits nuclear translocation of
STAT3
STAT3 is a key factor that negatively regulates p53
transcription by binding to its promoter (Niu et al.,
2005). We checked the subcellular localization of trans-
fected STAT3-EGFP either alone or in cells expressing the
3a protein. In control cells following EGF stimulation,
most of the STAT3 was found in the nuclear compartment
[Fig. 7a(i)]. However, in 3a protein-expressing cells under
similar conditions of EGF stimulation, STAT3 was retained
in the cytoplasm, showing a punctate distribution and co-
localization with the 3a protein [Fig. 7a(ii–iv)]. We tested
whether the 3a protein binds STAT3 to retain it in the
cytoplasm. In a co-immunoprecipitation assay, no direct
interaction was detected between these two proteins (data
not shown). To confirm further the inhibition of STAT3
nuclear translocation, we used a reporter gene transfection
assay in which plasmid pLucTKS3 containing a minimal
thymidine kinase promoter and seven STAT3 response
elements was used to drive luciferase expression.
Transiently transfected Huh7 cells showed a marked
reduction in luciferase activity when pLucTKS3 was co-
transfected with the pSG-3a expression plasmid compared
with the vector control (Fig. 7b). Furthermore, by Western
blotting, no significant differences were observed in the
levels of phospho-STAT3 and total STAT3 in control
versus 3a protein-expressing cells (Fig. 7c). Taken together,
these results showed that, in cells that express the SARS-
CoV 3a protein, there is reduced nuclear localization and
consequently decreased transcription factor activity of
STAT3.
DISCUSSION
The host uses apoptosis to limit virus replication and
remove virus-infected cells (Fujimoto et al., 2000).
Apoptosis can also assist in the dissemination of viral
particles and is the cause of tissue damage observed
following many viral infections (Lyles, 2000). In SARS
patients, apoptosis of cells of the lung epithelium has been
observed, suggesting SARS-CoV-induced apoptosis to have
a deleterious pathogenic role, leading to severe tissue
damage (Yan et al., 2004). There are indications that
apoptosis and the antiviral immune response may both
contribute to the pathology in SARS patients (Yang et al.,
2005).
The SARS-CoV 3a, 3b, nucleocapsid and 7a proteins have
been shown to induce apoptosis (Law et al., 2005; Yuan et
al., 2007). In Vero E6 cells that transiently express the 3a
protein, nuclear fragmentation, chromatin condensation,
DNA laddering and an increased terminal deoxynucleoti-
dyl transferase dUTP nick end-labelling signal have been
(a)
(b)
(c)
Fig. 5. (a) Huh7 cells were transfected with
expression plasmids for full-length or the
cytoplasmic domain of 3a protein. Lysates
prepared at 48 h p.t. were analysed by
Western blotting. (b) Left panels: Huh7 and
COS cells transfected with pSG-3a were
fixed, permeabilized and stained with antibod-
ies against 3a protein or caveolin-1, followed
by confocal microscopy. Right panels: lysates
prepared from cells at 48 h p.t. were analysed
by Western blotting against the indicated
proteins. (c) Lysates of transfected COS cells
at 48 h p.t. were cross-linked with DSS and
Western blotted for Bax. Cell lysates without
cross-linking were analysed for p53 and
caspase-9 levels.
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observed (Law et al., 2005). Furthermore, there was
increased caspase-8 activation, but no change in Bcl-2,
Bad or PCNA levels (Law et al., 2005). As caspase-8 is
downstream of the cell-surface death receptors (Green &
Kroemer, 2004) and Bcl-2 family protein levels regulate the
mitochondrial death signal (Zou et al., 1999), this
suggested that the 3a protein activated the extrinsic, but
not the intrinsic pathway of apoptosis. We studied Huh7
cells that transiently expressed the 3a protein to understand
its role in apoptosis. There was increased activation of
caspase-3 and -9 as well as cleavage of the caspase-3
substrate PARP in cells expressing the 3a protein. We also
observed increased levels of tBid in cells expressing the 3a
protein. The Bid protein is cleaved by caspase-8 to generate
tBid, which can form pores in the mitochondrial outer
membrane and is a key factor that links the extrinsic and
intrinsic pathways of apoptosis (Luo et al., 1998).
As caspase-9 is activated downstream of the mitochondrial
pathway of apoptosis (Zou et al., 1999), we looked for
cytochrome c release, a key feature of this pathway. This
was observed in cells expressing the 3a protein, confirming
a role for this protein in activating the intrinsic pathway as
well. The Bcl-2 family proteins are important regulators of
the intrinsic pathway (Adams & Cory, 1998). Whilst there
was no effect of the 3a protein on the levels of Bcl-2, Bcl-
XL, Mcl-1 and Bak, increased oligomerization of Bax was
observed in cells expressing the 3a protein. In viable cells,
Bax mainly exists as a monomer in the cytoplasm, but
upon apoptotic stimulation it undergoes conformational
changes and translocates to the mitochondria, where it
inserts into the outer membrane as oligomers; this results
in the release of cytochrome c and initiation of apoptosis
(Wolter et al., 1997).
What might be the cue for Bax oligomerization? Whilst
there are many cellular signals that regulate Bax levels, the
tumour suppressor protein p53 is unique in that it can
activate nuclear transcription of bax and it also promotes
cytoplasmic oligomerization of Bax monomers (Baptiste &
Prives, 2004). Increased levels of p53 were found in 3a
protein-expressing cells. The regulation of p53 is complex
and includes transcriptional as well as post-translational
events such as phosphorylation and acetylation (Meek,
1998). Phosphorylation at Ser-15 and Ser-37 disrupts the
interaction between p53 and MDM2, leading to increased
stability of p53 (Shieh et al., 1997). p38 MAPK activates
transcription as well as phosphorylation of p53 at Ser-15
(Bulavin et al., 1999; She et al., 2000), and p38 activation
was observed in cells that expressed the 3a protein. The
MAPKs are signal transducers that respond to extracellular
stimulation by cytokines, growth factors, virus infection
and stress, and in turn regulate cell differentiation,
proliferation, survival and apoptosis (Chang & Karin,
2001). p38 MAPK is involved in the cell-death cascade and
is strongly activated by stress and inflammatory cytokines
following phosphorylation of its Thr-180 and Tyr-182
residues by the upstream kinase MKK3/6 (Noh et al., 2000;
Yamagishi et al., 2001), which was also activated in 3a
protein-expressing cells. Whilst the upstream events that
induce a conformational change in Bax are still unclear,
recent studies suggest that caspase activation, Bid asso-
ciation and p38 MAPK initiate changes in Bax conforma-
tion, followed by its mitochondrial translocation (Desagher
et al., 1999; Ghatan et al., 2000). In SARS-CoV-infected
cells, there is increased activation of p38 MAPK and
phosphorylation of its downstream targets (Mizutani et al.,
2004). Here, we showed that the SARS-CoV 3a protein
activates p38 MAPK. The use of SB203580, an inhibitor of
p38 activity, showed that it was upstream of p53 and Bax in
the 3a protein-mediated apoptotic pathway. Direct flow
cytometric assays also showed increased levels of death in
cells expressing the 3a protein and inhibition of this
following SB203580 treatment. Thus, p38 MAPK activation
is an upstream effector of apoptosis directed by the SARS-
CoV 3a protein.
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Fig. 6. The apoptotic effect of the 3a protein is mediated by p38.
Transfected Huh7 cells were treated with SB203580 or not and
the cells stained for Annexin V and the 3a protein as described in
Methods. (a) Single-parameter overlay plot for cells gated on 3a
expression. (b) Percentage apoptosis (±SD) calculated over four
different experiments. The P values for the indicated sets were
calculated using Student’s t-test and values of P¡0.05 were
considered significant.
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The STAT proteins are transcription factors that mediate
virtually all cytokine-driven signalling (Darnell, 1997).
These proteins are latent in the cytoplasm and become
activated on tyrosine phosphorylation by cytokine or
growth factor receptor-associated kinases, dimerize, trans-
locate to the nucleus and activate target genes (Bromberg,
2002). Whilst the STAT proteins generally regulate cell-
cycle progression and apoptosis, STAT3 promotes cell-
cycle progression and cellular transformation, and prevents
apoptosis. It mediates a survival function by inducing the
expression of anti-apoptotic genes such as Bcl-2 and Bcl-XL
(Levy & Lee, 2002). STAT3 can also promote cell survival
by inhibiting the transcription of pro-apoptotic genes,
including p53 (Niu et al., 2005). Whilst we found no
change in the levels of either pSTAT3 or STAT3 following
expression of the 3a protein, there was a marked reduction
in the nuclear translocation of STAT3 and its transcription
factor activity in these cells.
The 3b, ORF6 and nucleocapsid proteins of SARS-CoV
function as interferon antagonists by inhibiting the
expression of beta interferon (Kopecky-Bromberg et al.,
2007). Of these, the ORF6 protein inhibits nuclear
translocation of STAT1, a transcription factor that is
required for the activation of interferon-responsive pro-
moters. Interestingly, this protein also showed no effect on
STAT1 phosphorylation. Our findings showed that the
SARS-CoV 3a protein does not affect STAT3 phosphoryla-
tion, but inhibits its nuclear entry. Analogous to effects of
ORF6 on STAT1, this could be one way of suppressing the
inhibitory effects of STAT3 on p53, leading to increased
p53 levels and its downstream effects on Bax and
promotion of apoptosis.
Earlier work has demonstrated apoptosis of SARS-CoV-
infected cells, and a role for the 3a protein was proposed
based on its activation of caspase-8 (Law et al., 2005).
Although caspase-8 is activated downstream of the
extrinsic death pathway, the mechanism(s) remained
unexplored. Here, we showed cleavage of Bid, a substrate
of caspase-8, and a link between the extrinsic and intrinsic
death pathways. Our results also showed that the 3a
protein promotes the intrinsic death pathway, which
involves the release of mitochondrial cytochrome c and
the downstream activation of caspase-9. In cells expressing
the 3a protein, the stress pathway is activated, which
includes activation of p38 MAP kinase, a concomitant
increase in p53 levels, increased Bax oligomerization and
cytochrome c release. Mitochondrial depolarization and
cytochrome c release would result from the effects of tBid
as well as Bax oligomers, and both pathways appear to
function downstream of the 3a protein. This is also
reflected in the reversal of only about half of cell death by
SB203580 in cells expressing the 3a protein. Whilst the
intrinsic pathway, through caspase-9, Bax and p53, is
dependent upon p38 MAPK, the extrinsic pathway
operating through caspase-8 would be independent of it
(Fig. 8). We also observed reduced nuclear translocation of
STAT3 in 3a protein-expressing cells; this is likely to inhibit
the expression of survival genes and to relieve STAT3-
mediated inhibition of p53 expression. Taken together, we
propose that the SARS-CoV 3a protein utilizes multiple
pathways (Fig. 8) to promote apoptosis.
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Fig. 7. The 3a protein blocks the nuclear
translocation of STAT3. (a) Huh7 cells were
co-transfected with the STAT3-EGFP and 3a-
DsRed expression constructs. Transfected
cells were stimulated with EGF, fixed and
analysed by confocal microscopy for STAT3
and 3a protein localization. The pseudo-
coloured and merged images are shown. (b)
Huh7 cells were co-transfected with the
indicated plasmids. After 48 h, cell lysates
were prepared, normalized for protein content
and assayed for luciferase activity as
described in Methods. The graph shows the
results from three separate experiments. (c)
Lysates prepared from cells at 48 h p.t. with
the indicated vectors were separated by SDS-
PAGE and analysed by Western blotting.
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